{"title":"Synergistic inhibition of hepatocarcinogenesis by green alga Ulva lactuca polysaccharide and 5-fluorouracil targeted SERPINH1","authors":"Wei Liao , Shuo Shan , Jingxiang Xu , Zhengxin Chen , Yinfeng Wu , Yuxi Wen , Weichao Chen , Chao Zhao","doi":"10.1016/j.phymed.2025.157266","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The serpin family H member 1 (SERPINH1) as a collagen-specific molecular chaperone, plays a crucial role in the biosynthesis of collagen. However, its function in hepatocellular carcinoma (HCC) is largely unexplored.</div></div><div><h3>Purpose</h3><div>To elucidate the mechanism which the combination of <em>Ulva lactuca</em> polysaccharide (ULP) and 5-fluorouracil (5-FU) synergistically inhibits tumors via targeting SERPINH1.</div></div><div><h3>Methods</h3><div>This study employed <em>in vitro</em> (RAW264.7 and HepG2 cells) and <em>in vivo</em> (H22 tumor-bearing mouse and xenograft zebrafish) models to investigate the mechanisms behind the synergistic antitumor effects and attenuated cytotoxicity of the ULP and 5-FU combination. RNA sequencing (RNA-seq) coupled with bioinformatic analyses was employed to explore the potential carcinogenesis and tumor-suppressive roles of SERPINH1. Furthermore, siRNA-mediated knockdown of SERPINH1 was performed to confirm its functional significance in HCC.</div></div><div><h3>Results</h3><div>A combination of ULP and 5-FU augments tumor cell inhibition and alleviates oxidative stress damage caused by chemotherapy. ULP and 5-FU inhibited collagen secretion by downregulating SERPINH1 expression, thereby impairing extracellular matrix (ECM) deposition. Consequently, this led to the suppression of invasion and migration in HepG2 cells.</div></div><div><h3>Conclusion</h3><div>ULP is identified as a novel natural agent that synergizes with 5-FU to suppress tumor progression, primarily by modulating the ECM. The combination treatment targets SERPINH1, inhibiting collagen-mediated ECM deposition and consequently reducing tumor cell migration and invasion.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"148 ","pages":"Article 157266"},"PeriodicalIF":8.3000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytomedicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0944711325009055","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The serpin family H member 1 (SERPINH1) as a collagen-specific molecular chaperone, plays a crucial role in the biosynthesis of collagen. However, its function in hepatocellular carcinoma (HCC) is largely unexplored.
Purpose
To elucidate the mechanism which the combination of Ulva lactuca polysaccharide (ULP) and 5-fluorouracil (5-FU) synergistically inhibits tumors via targeting SERPINH1.
Methods
This study employed in vitro (RAW264.7 and HepG2 cells) and in vivo (H22 tumor-bearing mouse and xenograft zebrafish) models to investigate the mechanisms behind the synergistic antitumor effects and attenuated cytotoxicity of the ULP and 5-FU combination. RNA sequencing (RNA-seq) coupled with bioinformatic analyses was employed to explore the potential carcinogenesis and tumor-suppressive roles of SERPINH1. Furthermore, siRNA-mediated knockdown of SERPINH1 was performed to confirm its functional significance in HCC.
Results
A combination of ULP and 5-FU augments tumor cell inhibition and alleviates oxidative stress damage caused by chemotherapy. ULP and 5-FU inhibited collagen secretion by downregulating SERPINH1 expression, thereby impairing extracellular matrix (ECM) deposition. Consequently, this led to the suppression of invasion and migration in HepG2 cells.
Conclusion
ULP is identified as a novel natural agent that synergizes with 5-FU to suppress tumor progression, primarily by modulating the ECM. The combination treatment targets SERPINH1, inhibiting collagen-mediated ECM deposition and consequently reducing tumor cell migration and invasion.
期刊介绍:
Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.